Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Artrya Ltd logo — We are changing the way Coronary Heart Disease is diagnosed...

Artrya Ltd

We are changing the way Coronary Heart Disease is diagnosed and treated.

Founded 2018 Australia Australia 44 employees Series A Total: $15.00M AI, Biotechnology +2

General Information

Company Name Artrya Ltd
Founded Year 2018
Location Australia Australia +1
Employees 44
Industries AI, Biotechnology, Health Care +1
Funding Stage Series A
Social

Get notified when Artrya Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Artrya Ltd

Artrya is an applied artificial intelligence healthcare company that aims to revolutionize the diagnosis and treatment of Coronary Heart Disease. Founded in 2019 and headquartered in Australia, the company has garnered significant attention in the Biotechnology and Health Care industries. Artrya's recent Series A investment of $15.00M on 25 May 2021 brought onboard notable investors including Regal Funds Management, Washington H. Soul Pattinson, Watermark Funds Management, and Thorney Investment. The company's mission to collaboratively enhance coronary disease diagnosis with clinicians through deep learning algorithms showcases its commitment to predictive and preventive healthcare. Artrya's innovative approach, as reflected in their slogan "We are changing the way Coronary Heart Disease is diagnosed and treated," underscores the potential impact on patient care and industry advancements. With a focus on developing a comprehensive patient risk assessment, Artrya aims to address crucial gaps in existing healthcare systems.

Taxonomy: coronary heart disease, diagnosis, treatment, deep learning algorithms, acute coronary events, prediction, prevention, diagnostic accuracy, medical services, ageing population, health system costs, patient risk assessment, clinical support

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor
•••• •••• 		25 May 2021

Artrya Ltd Alternatives & Competitors

Artrya Ltd vs
Miracor Medical SA
Miracor Medical SA Belgium

Miracor develops the PiCSO Impulse System to improve coronary microcirculation & reduce infarct size...

Series E
7 employees
Health Care, Health and Wellness
Compare Artrya Ltd vs Miracor Medical SA
Artrya Ltd vs
Kaminari Medical
Kaminari Medical The Netherlands

Combining ultrasound and optical imaging to revolutionize coronary revascularization

Seed
7 employees
Health Care, Medical Devices
Compare Artrya Ltd vs Kaminari Medical
Artrya Ltd vs
Life Flow
Life Flow

Leading the way in non-invasive cardiac diagnostics with advanced Computational Fluid Dynamics techn...

Seed
51-200 employees
Health Care, Life Sciences
Compare Artrya Ltd vs Life Flow

FAQ About Artrya Ltd

We are changing the way Coronary Heart Disease is diagnosed and treated.
Artrya Ltd was founded in 2018.
Artrya Ltd is headquartered in Australia.
Artrya Ltd operates in the following industries: AI, Biotechnology, Health Care, Machine Learning.
Artrya Ltd has approximately 44 employees.
Artrya Ltd has completed 1 funding round, raising a total of $15.00M. The latest funding stage is Series A.
Top alternatives and competitors to Artrya Ltd include Miracor Medical SA, Kaminari Medical, Life Flow, Heartflow, Barty Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Artrya Ltd and Miracor Medical SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Artrya Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy